本頁面由Tiger Trade Technology Pte. Ltd.提供服務

百濟神州

275.28
-7.4400-2.63%
盤後275.280.00000.00%16:15 EDT
成交量:22.67萬
成交額:6,301.42萬
市值:305.56億
市盈率:528.98
高:285.50
開:282.43
低:274.97
收:282.72
52周最高:385.22
52周最低:196.45
股本:1.11億
流通股本:8,557.73萬
量比:1.11
換手率:0.26%
股息:- -
股息率:- -
每股收益(TTM):0.5204
每股收益(LYR):2.47
淨資產收益率:7.46%
總資產收益率:3.96%
市淨率:7.01
市盈率(LYR):111.45

資料載入中...

2026/02/26

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report
2026/02/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

重要事件披露

Form 8-K - Current report
2025/12/18

重要事件披露

Form 8-K - Current report
2025/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/19

重要事件披露

Form 8-K - Current report
2025/11/17

關聯方擬減持公告

Form 144 | BeOne Medicines Ltd. 高管 Xiaobin Wu 擬減持3991股,總價約151.83萬美元
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/16

關聯方擬減持公告

Form 144 | BeOne Medicines Ltd.高管 PAN-OYLER FOUNDATION 擬減持1204股,總價約40萬美元
2025/09/16

關聯方擬減持公告

Form 144 | BeOne Medicines高管John V Oyler擬減持27803股,總價約923.81萬美元
2025/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities